Pope C., Karanth S., Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ. Toxicol. Pharmacol. 2005, 19:433-446.
Singh M., Kaur M., Kukreja H., Chugh R., Silakari O., Singh D. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur. J. Med. Chem. 2013, 70:165-188.
Grossberg G.T. Cholinesterase inhibitors for the treatment of Alzheimer's disease: getting on and staying on. Curr. Ther. Res. Clin. Exp. 2003, 64:216-235.
Racchi M., Mazzucchelli M., Porrello E., Lanni C., Govoni S. Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol. Res. 2004, 50:441-451.
Mehta M., Adem A., Sabbagh M. New acetylcholinesterase inhibitors for Alzheimer's disease. Int. J. Alzheimers Dis. 2012, 2012:1-8.
Silman I., Sussman J.L. Acetylcholinesterase "classical" and "non-classical" functions and pharmacology. Curr. Opin. Pharmacol. 2005, 5:293-302.
Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2011, 155:219-230.
Han S., Sweeney J., Bachman E., Schweiger E., Forloni G., Coyle J., et al. Chemical and pharmacological characterization of galanthamine, an acetylcholinesterase inhibitor, and its derivatives. A potential application in Alzheimer's disease?. Eur. J. Med. Chem. 1992, 27:673-687.
Pinho B.R., Ferreres F., Valentão P., Andrade P.B. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment. J. Pharm. Pharmacol. 2013, 65:1681-1700.
Mukherjee P.K., Kumar V., Mal M., Houghton P.J. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007, 14:289-300.
Barbosa Filho J.M., Medeiros K.C.P., de M., Diniz F.F.M., Batista L.M., Athayde-Filho P.F., Silva M.S., et al. Natural products inhibitors of the enzyme acetylcholinesterase. Rev. Bras. Farmacogn. 2006, 16:258-285.
Islam M.R., Zaman A., Jahan I., Chakravorty R., Chakraborty S. In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease. J. Young Pharm. 2013, 5:173-179.
Gomes N.G.M., Campos M.G., Orfão J.M.C., Ribeiro C.A.F. Plants with neurobiological activity as potential targets for drug discovery. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1372-1389.
Min W., Wang W., Chen J., Wang A., Hu Z. On-line immobilized acetylcholinesterase microreactor for screening of inhibitors from natural extracts by capillary electrophoresis. Anal. Bioanal. Chem. 2012, 404:2397-2405.
Erdogan Orhan I., Orhan G., Gurkas E. An overview on natural cholinesterase inhibitors - a multi-targeted drug class - and their mass production. Mini Rev. Med. Chem. 2011, 11:836-842.
Wang R., Yan H., Tang X. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 2006, 27:1-26.
Miao Y., He N., Zhu J.-J. History and new developments of assays for cholinesterase activity and inhibition. Chem. Rev. 2010, 110:5216-5234.
Bartolini M., Cavrini V., Andrisano V. Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. J. Chromatogr. A 2005, 1065:135-144.
Bartolini M., Cavrini V., Andrisano V. Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor. J. Chromatogr. A 2007, 1144:102-110.
Wang M., Gu X., Zhang G., Zhang D., Zhu D. Continuous colorimetric assay for acetylcholinesterase and inhibitor screening with gold nanoparticles. Langmuir 2009, 25:2504-2507.
Monton M.R.N., Lebert J.M., Little J.R.L., Nair J.J., McNulty J., Brennan J.D. A sol-gel-derived acetylcholinesterase microarray for nanovolume small-molecule screening. Anal. Chem. 2010, 82:9365-9373.
Parsajoo C., Kauffmann J.-M. Development of an acetylcholinesterase immobilized flow through amperometric detector based on thiocholine detection at a silver electrode. Talanta 2013, 109:116-120.
Hsieh B.-C., Matsumoto K., Cheng T.-J., Yuu G., Chen R.L.C. Choline biosensor constructed with chitinous membrane from soldier crab and its application in measuring cholinesterase inhibitory activities. J. Pharm. Biomed. Anal. 2007, 45:673-678.
Hu F., Zhang H., Lin H., Deng C., Zhang X. Enzyme inhibitor screening by electrospray mass spectrometry with immobilized enzyme on magnetic silica microspheres. J. Am. Soc. Mass Spectrom. 2008, 19:865-873.
Milkani E., Lambert C.R., McGimpsey W.G. Direct detection of acetylcholinesterase inhibitor binding with an enzyme-based surface plasmon resonance sensor. Anal. Biochem. 2011, 408:212-219.
Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
Lenigk R., Lam E., Lai A., Wang H., Han Y., Carlier P., et al. Enzyme biosensor for studying therapeutics of Alzheimer's disease. Biosens. Bioelectron. 2000, 15:541-547.
Ricci F., Arduini F., Amine A., Moscone D., Palleschi G. Characterisation of Prussian blue modified screen-printed electrodes for thiol detection. J. Electroanal. Chem. 2004, 563:229-237.
Shaidarova L.G., Fomin A.Y., Ziganshina S.A., Medyantseva E.P., Budnikov G.K. Electrocatalytic response of electrodes modified with metal phthalocyanines in the cholinesterase-thiocholine ester system. J. Anal. Chem. 2002, 57:150-156.
Tang Z.-M., Wang Z.-Y., Kang J.-W. Screening of acetylcholinesterase inhibitors in natural extracts by CE with electrophoretically mediated microanalysis technique. Electrophoresis 2007, 28:360-365.
Huang L., Shi A., He F., Li X. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorg. Med. Chem. 2010, 18:1244-1251.
Bhutada P., Mundhada Y., Bansod K., Tawari S., Patil S., Dixit P., et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav. Brain Res. 2011, 220:30-41.
Khan M.T.H., Orhan I., Senol F.S., Kartal M., Sener B., Dvorská M., et al. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem. Biol. Interact. 2009, 181:383-389.
Arduini F., Guidone S., Amine A., Palleschi G., Moscone D. Acetylcholinesterase biosensor based on self-assembled monolayer-modified gold-screen printed electrodes for organophosphorus insecticide detection. Sens. Actuators B: Chem. 2013, 179:201-208.
Sarakbi A., Aydogmus Z., Dago A., Mertens D., Dewert J.-Y., Kauffmann J.-M. Determination of aminothiols by liquid chromatography with amperometric detection at a silver electrode: application to white wines. Anal. Chim. Acta 2013, 786:22-28.
Giuriati C., Cavalli S., Gorni A., Badocco D., Pastore P. Ion chromatographic determination of sulfide and cyanide in real matrices by using pulsed amperometric detection on a silver electrode. J. Chromatogr. A 2004, 1023:105-112.
Kamal M.M. Voltammetric studies on the surface activity and orientation of 2-thiobarbituric acid at the mercury/solution interface. J. Electroanal. Chem. Interfacial Electrochem. 1991, 321:359-366.
da Silva J.I., de Moraes M.C., Vieira L.C.C., Corrêa A.G., Cass Q.B., Cardoso C.L. Acetylcholinesterase capillary enzyme reactor for screening and characterization of selective inhibitors. J. Pharm. Biomed. Anal. 2013, 73:44-52.
Pietsch M., Christian L., Inhester T., Petzold S., Gütschow M. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile. FEBS J. 2009, 276:2292-2307.
Plummer J.M., Greenberg M.J., Lehman H.K., Watts J.A. Competitive inhibition by dimethylsulfoxide of molluscan and vertebrate acetylcholinesterase. Biochem. Pharmacol. 1983, 32:151-158.
Ingkaninan K., de Best C.M., van der Heijden R., Hofte A.J.P., Karabatak B., Irth H., et al. High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products. J. Chromatogr. A 2000, 872:61-73.
Obregon A.D.C., Schetinger M.R.C., Correa M.M., Morsch V.M., da Silva J.E.P., Martins M.A.P., et al. Effects per se of organic solvents in the cerebral acetylcholinesterase of rats. Neurochem. Res. 2005, 30:379-384.
Dvir H., Silman I., Harel M., Rosenberry T.L., Sussman J.L. Acetylcholinesterase: from 3D structure to function. Chem. Biol. Interact. 2010, 187:10-22.
Soreq H. Human Cholinesterases and Anticholinesterases 1993, Academic Press, London.
Yu Q.-S., Holloway H.W., Luo W., Lahiri D.K., Brossi A., Greig N.H. Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg. Med. Chem. 2010, 18:4687-4693.
Nair V.P. Anticholinesterases and anticholinergic drugs. Contin. Educ. Anaesth. Crit. Care Pain 2004, 4:164-168.
Bar-On P., Millard C.B., Harel M., Dvir H., Enz A., Sussman J.L., et al. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry 2002, 41:3555-3564.
Nordberg A., Ballard C., Bullock R., Darreh-Shori T., Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. Prim. Care Companion CNS Disord. 2013, 15:1-44.
Enz A., Amstutz R., Boddeke H., Gmelin G., Malanowski J. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog. Brain Res. 1993, 98:431-438.
Sugimoto H., Ogura H., Arai Y., Limura Y., Yamanishi Y. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn. J. Pharmacol. 2002, 89:7-20.
Wilkinson D.G. The pharmacology of donepezil: a new treatment of Alzheimer's disease. Expert Opin. Pharmacother. 1999, 1:121-135.
del Monte-Millán M., García-Palomero E., Valenzuela R., Usán P., de Austria C., Muñoz-Ruiz P., et al. Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD. J. Mol. Neurosci. 2006, 30:85-88.
Inestrosa N.C., Dinamarca M.C., Alvarez A. Amyloid-cholinesterase interactions. Implications for Alzheimer's disease. FEBS J. 2008, 275:625-632.
Martín-Biosca Y., Asensi-Bernardi L., Villanueva-Camañas R.M., Sagrado S., Medina-Hernández M.J. Screening of acetylcholinesterase inhibitors by CE after enzymatic reaction at capillary inlet. J. Sep. Sci. 2009, 32:1748-1756.
Perola E., Cellai L., Lamba D., Filocamo L., Brufani M. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase. Biochim. Biophys. Acta: Protein Struct. Mol. Enzymol. 1997, 1343:41-50.
Coelho F., Birks J. Physostigmine for Alzheimer's disease. Cochrane Database Syst. Rev. 2001, 1-85.
